These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17675499)

  • 1. O-glycosylated human MUC1 repeats are processed in vitro by immunoproteasomes.
    Ninkovic T; Hanisch FG
    J Immunol; 2007 Aug; 179(4):2380-8. PubMed ID: 17675499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer associated aberrant protein O-glycosylation can modify antigen processing and immune response.
    Madsen CB; Petersen C; Lavrsen K; Harndahl M; Buus S; Clausen H; Pedersen AE; Wandall HH
    PLoS One; 2012; 7(11):e50139. PubMed ID: 23189185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology of O-glycosylated proteins: approaches to the design of a MUC1 glycopeptide-based tumor vaccine.
    Hanisch FG; Ninkovic T
    Curr Protein Pept Sci; 2006 Aug; 7(4):307-15. PubMed ID: 16918445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes.
    Ninkovic T; Kinarsky L; Engelmann K; Pisarev V; Sherman S; Finn OJ; Hanisch FG
    Mol Immunol; 2009 Nov; 47(1):131-40. PubMed ID: 19007994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-Linked glycans control glycoprotein processing by antigen-presenting cells: a biochemical approach to the molecular aspects of MUC1 processing by dendritic cells.
    Hanisch FG; Schwientek T; Von Bergwelt-Baildon MS; Schultze JL; Finn O
    Eur J Immunol; 2003 Dec; 33(12):3242-54. PubMed ID: 14635032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine.
    Lakshminarayanan V; Thompson P; Wolfert MA; Buskas T; Bradley JM; Pathangey LB; Madsen CS; Cohen PA; Gendler SJ; Boons GJ
    Proc Natl Acad Sci U S A; 2012 Jan; 109(1):261-6. PubMed ID: 22171012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken Up by dendritic cells.
    Hiltbold EM; Alter MD; Ciborowski P; Finn OJ
    Cell Immunol; 1999 Jun; 194(2):143-9. PubMed ID: 10383817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of a MUC1-based cancer vaccine.
    Hanisch FG
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):705-8. PubMed ID: 16042579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making the most of mucin: a novel target for tumor immunotherapy.
    Barratt-Boyes SM
    Cancer Immunol Immunother; 1996 Nov; 43(3):142-51. PubMed ID: 9001567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
    Hanisch FG; Stadie T; Bosslet K
    Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of aberrantly glycosylated tumor mucin-1 on human DC after transduction with a fiber-modified adenoviral vector.
    van Leeuwen EB; Cloosen S; Senden-Gijsbers BL; Agervig Tarp M; Mandel U; Clausen H; Havenga MJ; Duffour MT; García-Vallejo JJ; Germeraad WT; Bos GM
    Cytotherapy; 2006; 8(1):24-35. PubMed ID: 16627342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.
    Saeland E; van Vliet SJ; Bäckström M; van den Berg VC; Geijtenbeek TB; Meijer GA; van Kooyk Y
    Cancer Immunol Immunother; 2007 Aug; 56(8):1225-36. PubMed ID: 17195076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA.
    Dörfel D; Appel S; Grünebach F; Weck MM; Müller MR; Heine A; Brossart P
    Blood; 2005 Apr; 105(8):3199-205. PubMed ID: 15618468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma.
    Stepensky D; Tzehoval E; Vadai E; Eisenbach L
    Clin Exp Immunol; 2006 Jan; 143(1):139-49. PubMed ID: 16367945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
    Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
    J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the order and site specificity of GalNAc transfer to MUC1 tandem repeats by UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase from milk or mammary carcinoma cells.
    Stadie TR; Chai W; Lawson AM; Byfield PG; Hanisch FG
    Eur J Biochem; 1995 Apr; 229(1):140-7. PubMed ID: 7744025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue.
    Gad M; Jensen T; Gagne R; Komba S; Daugaard S; Kroman N; Meldal M; Werdelin O
    Eur J Immunol; 2003 Jun; 33(6):1624-32. PubMed ID: 12778480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide mimics of a tumor antigen induce functional cytotoxic T cells.
    Apostolopoulos V; Lofthouse SA; Popovski V; Chelvanayagam G; Sandrin MS; McKenzie IF
    Nat Biotechnol; 1998 Mar; 16(3):276-80. PubMed ID: 9528009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts.
    Nishimori I; Perini F; Mountjoy KP; Sanderson SD; Johnson N; Cerny RL; Gross ML; Fontenot JD; Hollingsworth MA
    Cancer Res; 1994 Jul; 54(14):3738-44. PubMed ID: 8033093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.